SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,606.75 482.92
( 0.66%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,433.43 -259.73
(-0.41%)

Nikkei 225

10,766.40 76.04
(0.71%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

45.21

12855.76

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.61

Back

bn holdings ltd

Tilak Ventures standalone net profit rises 95.48% in the June 2026 quarter

Aug 14,2026

Net profit of Tilak Ventures rose 95.48% to Rs 4.32 crore in the quarter ended June 2026 as against Rs 2.21 crore during the previous quarter ended June 2025. Sales declined 19.48% to Rs 6.49 crore in the quarter ended June 2026 as against Rs 8.06 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	6.49	8.06	-19
OPM %	49.15	22.70	-
PBDT	5.77	3.15	83
PBT	5.77	3.15	83
NP	4.32	2.21	95

73,606.75 482.92 ( 0.66%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,433.43 -259.73 (-0.41%)

10,766.40 76.04 (0.71%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)